Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Trial Profile

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs Somatropin (Primary)
  • Indications Growth disorders
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Feb 2016 New trial record
    • 17 Feb 2016 Interim results (n=249) published in the Advances in Therapy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top